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ABSTRACT
Background and Purpose
Palliative radiotherapy (p r t ) is a routine part of on-
cology care in adult patients, but it is used much less 
frequently among children with incurable cancer. 
We surveyed Canadian pediatric oncologists to learn 
about their knowledge and use of p r t  and to identify 
potential barriers to referral.
Methods
A 13-item questionnaire assessing p r t  knowledge 
and utilization was sent to 80 Canadian pediatric 
oncologists.
Results
The survey completion rate was 80%, with most 
respondents being providers of palliative care for 
children and making referrals for p r t . Although 62% 
had received training in radiation oncology, only 28% 
had received formal palliative care training. Respon-
dents with palliative care training were found to be 
significantly more knowledgeable about p r t  and were 
more likely to refer children for p r t  (p < 0.01). Only 
59% of respondents thought that they had adequate 
knowledge about the indications for p r t . A positive 
correlation was found between knowledge about 
the indications for p r t  and referral for treatment (p 
< 0.01). Among survey respondents, 51% believed that 
p r t  was underutilized, and the perceived barriers to p r t  
referral included patient or family reluctance, distance 
to the cancer centre, belief that p r t  has little impact on 
quality of life, and concerns about toxicity.
Conclusions
Palliative radiotherapy is considered to be underuti-
lized among children. This situation appears to be 
related, in part, to inadequate knowledge and training 
among pediatric oncologists, suggesting that more 
emphasis needs to be placed on pediatric palliative 
care education.
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1.  INTRODUCTION
Radiotherapy plays a vital role in the management of 
many patients with cancer, in both treatment intended 
for cure and treatment in which the primary intent is 
palliation of symptoms. In fact, radiotherapy for pal-
liative purposes can represent up to 30%–50% of the 
radiotherapy workload in some radiation oncology 
programs 1,2. As a result, radiotherapy is an essential 
part of any comprehensive palliative care program 3,4. 
But despite the growing literature to support the use 
of palliative radiotherapy for symptom management 
and quality-of-life improvement 1,5–8 in adult patients, 
there remains a problem of underutilization of this 
treatment option 2–4,9. Several reasons for under-
utilization have been identified, including short life 
expectancy for the patient, transportation difficulties, 
lack of a coordinated team approach to end-of-life 
care, and a lack of comfort on the part of primary 
physicians with their radiotherapy knowledge 4,9–11.
Literature pertaining to palliative care in children 
with cancer is less available. Although cancer is not as 
prevalent in children as it is in adults, it is the second 
leading cause of death, after accidents, and the leading 
cause of death from non-accidental causes 12. Every 
year, approximately 850 children are diagnosed with 
cancer in Canada 13. Children often receive aggres-
sive treatment until the end of life. The idea of giving 
palliative treatment to a child may not be welcomed 
by either the parents or the physicians, because the 
intent to cure remains a priority, and extending life 
may be perceived to be more important than promot-
ing comfort 14. As well, few palliative care physicians 
or pediatricians in Canada have specific training and 
expertise in pediatric palliative care.
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Although there is evidence to suggest that ra-
diotherapy is effective in the palliation of metastasis 
to bone, brain, and liver, and of painful soft-tissue 
sites in children 15–18, information about the use of 
palliative radiotherapy for symptom management 
in children is scarce. A number of constraints may 
potentially limit the use of palliative radiation in 
children, including lack of knowledge on the part of 
the clinician and concerns that the treatment may be 
too traumatic or may not significantly contribute to 
the child’s quality of life.
The present study was carried out to determine the 
level of knowledge about the indications for, and the 
current utilization of, palliative radiotherapy among 
pediatric oncologists in Canada. Barriers to the utili-
zation of palliative radiotherapy were explored.
2.  MATERIALS AND METHODS
A panel consisting of a radiation oncologist (RSS) 
and two palliative care experts (TLT, EJF), one with 
a clinical background in pediatric oncology (TLT), 
developed a 13-item questionnaire to evaluate knowl-
edge and utilization of palliative radiotherapy among 
pediatric oncologists (Appendix a).
Participants were asked questions about the 
number of pediatric patients seen for palliative 
care, the number of referrals made for palliative 
radiotherapy, and the indications for which patients 
were referred for radiotherapy. Respondents were 
prompted with a list of 12 potential indications from 
which to choose and were given the opportunity to 
identify others. They were asked to identify how 
much training they had received in palliative care 
and in radiation oncology.
General knowledge of palliative radiation was 
evaluated through correct responses to a list of 12 
potential indications. Participants were asked to 
choose from a 4-point Likert scale including “Not 
effective,” “Somewhat effective,” “Very effective,” 
and “Don’t know.” Correct answers were determined 
by the radiation oncology expert (RSS) in consulta-
tion with currently available literature.
Ten perceived barriers to the use of palliative 
radiotherapy were listed, and participants were asked 
to rate how much influence each barrier had on their 
decision to refer for palliative radiotherapy: “Not at 
all,” “A little,” “Somewhat,” or “A lot.”
Participants were asked whether they felt that 
they had enough knowledge to identify indications 
for palliative radiotherapy and which harmful side 
effects discouraged them from referral. They were 
also asked to identify perceived barriers to their use 
of palliative radiotherapy.
Most pediatric oncology care is delivered in 
pediatric hospitals in Canada, and so names and 
addresses of potential participants were identified 
through telephone contact with all pediatric hospitals 
in the country. An initial anonymous questionnaire 
was sent in December 2005, and a reminder was 
sent in January 2006. The completed questionnaires 
were collected, and responses were collated. The data 
were analyzed using the SPSS statistical software 
package (version 13: SPSS, Chicago, IL, U.S.A.), 
and a profile of pediatric oncologists who reported 
referring patients for palliative radiotherapy was 
constructed using multivariate logistic regression 
modeling techniques.
3.  RESULTS
Surveys were sent to 80 pediatric oncologists across 
Canada for whom addresses were available—a group 
that represented a majority of these specialists among 
the estimated 90 in the country. One returned survey 
was not completed and was therefore ineligible for 
analysis; 64 completed surveys were returned, for a 
survey completion rate of 80%. Most of the respond-
ing clinicians (92%) had provided palliative care for 
children with cancer within the preceding 12 months, 
and 80% had referred children for palliative radiother-
apy during that time. Most of the respondents (96%) 
had referred 1–5 patients for palliative radiotherapy 
during the preceding 12 months.
3.1  Training
Of the survey respondents, 62% had received training 
in radiation oncology, at a median length of 4 weeks. 
Only 28% of respondents had received formal pal-
liative care training. Previous palliative care training 
had a significant effect on referral rates for palliative 
radiotherapy: 94% of respondents who had received 
palliative training had made referrals, compared with 
73% of respondents who had received no previous 
palliative training (p < 0.01).
3.2  Knowledge
Of all respondents, 59% felt that they had adequate 
knowledge to identify indications for palliative radio-
therapy among their patients; the other 41% responded 
“no” or “unsure.” Of respondents who had received 
palliative care training, 67% were confident in their 
knowledge of palliative radiotherapy; only 56% of 
those who had not received palliative care training 
were confident in their knowledge (p < 0.05).
Figure 1 shows knowledge of the effectiveness of 
palliative radiotherapy for specific indications. “Very 
effective” was considered to be correct for painful 
bone and soft-tissue metastasis, bleeding masses, 
and hemoptysis; “somewhat” or “very effective” 
were considered correct for the remaining indica-
tions. Knowledge of the effectiveness of palliative 
radiotherapy for bone metastasis, soft-tissue metas-
tasis, and dyspnea was considered adequate in 89%, 
61%, and 80% of respondents respectively. However, 
knowledge of palliative radiotherapy for bleeding 50
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tumour masses and hemoptysis was considered 
adequate in only 40% and 22% of respondents; 45% 
and 64% were unsure of the effectiveness of palliative 
radiotherapy for those indications.
Significant correlations were observed be-
tween referrals and knowledge of radiotherapy 
indications. In the group of respondents that made 
referrals for radiotherapy for bone metastasis, 
98% demonstrated adequate knowledge for that 
indication. However, among respondents who 
made no referrals for bone metastasis, only 79% 
demonstrated adequate knowledge (p < 0.01). A 
positive correlation was also found between limited 
knowledge about the use of palliative radiotherapy 
for hemoptysis and bleeding tumour masses and the 
low utilization of palliative radiotherapy for those 
indications (p < 0.01).
3.3  Utilization
Among the 64 survey respondents, 39% had provided 
palliative care for 6 or more pediatric patients in the 
12 months before the survey; 55% had provided pal-
liative care for only 1–5 patients in that period. Only 
4% of respondents had referred more than 5 children 
for palliative radiotherapy.
Respondents were asked if they had referred 
patients for palliative radiotherapy for each of the 
indications shown in Figure 2. Radiotherapy referrals 
were most commonly made for bone metastasis, spi-
nal cord compression, and a painful soft-tissue mass. 
Only 2 respondents (3%) had referred patients for 
palliative radiotherapy for hemoptysis, and 2 (3%), 
for a bleeding tumour mass. Dyspnea because of in-
trathoracic tumours led to referrals by 14 respondents 
(22%), and 51% of respondents felt that palliative 
radiotherapy was underutilized in that population 
(19% were unsure).
When given the opportunity to comment on why 
they felt that radiotherapy was underutilized, most 
respondents offered no opinion. However, issues 
related to limited published literature and difficulties 
in coordinating treatment (especially if a radiotherapy 
facility was not close by) were mentioned.
3.4  Barriers to Utilization
Of the survey respondents, 92% had access to a radia-
tion oncologist with expertise in pediatric radiation 
therapy, and 94% routinely considered radiation 
therapy for their patients. As noted, however, ap-
proximately half (51%) the respondents felt that pal-
liative radiotherapy is underutilized. Figure 3 outlines 
factors that negatively influenced the decision to 
refer a patient for palliative radiotherapy. Patient and 
family reluctance were the most prominent reasons 
identified, as were proximity to the cancer center and 
the idea that radiation treatment has little impact on 
quality of life.
When asked to provide details explaining previ-
ous experience with radiotherapy that discouraged 
referrals for palliative reasons, respondents identified 
nausea and vomiting that could not be well man-
aged, fear of second malignancy, severe mucositis 
negatively affecting quality of life, and skin burns 
with ulceration and necrosis. Table i shows some of 
the most interesting comments by respondents about 
their perspectives on palliative radiotherapy.
4.  DISCUSSION
Results from this study indicate that most pediat-
ric oncologists in Canada perceive that they have 
f i g u r e  1  Knowledge about the effectiveness of palliative radio-
therapy for various cancer-related symptoms. s V C O  = superior vena 
cava obstruction. f i g u r e  2  Utilization of palliative radiotherapy for various cancer-
related symptoms. s V C O  = superior vena cava obstruction.
f i g u r e  3  Factors influencing a decision to refer for palliative 
radiotherapy: perspectives from pediatric oncologists. q O l  = qual-
ity of life.51
Cu r r e n t On C O l O g y —VO l u m e  17, nu m b e r 1
adequate knowledge about the indications for pal-
liative radiotherapy; however, at least half feel that 
palliative radiotherapy is underutilized. The exact 
reasons for this perceived underutilization remain 
unclear. Published studies 4,9–11 have attributed this 
radiotherapy underutilization to a number of factors 
(Table ii). Interestingly, many of the same barriers 
or concerns were reported by our respondents. In 
the pediatric population, as in the adult population, 
many of these issues can and should be addressed 
using initiatives such as improved education and 
training, better communication with patients and 
families, and (among health care professionals) bet-
ter coordination of care (to reduce patient wait times 
and inconvenience) and development of treatment 
guidelines. Given that ample evidence shows that pal-
liative radiotherapy can effectively and fairly quickly 
improve symptoms and quality of life with relatively 
little morbidity, and often with very short courses of 
treatment, radiotherapy efficacy and toxicity should 
not be a major issue. Canada’s universal health care 
coverage means that radiotherapy costs are not an 
issue for patients, and it has even been suggested 
that increased use of palliative radiotherapy could not 
only increase quality of life for patients, but actually 
reduce overall costs for end-of-life care 4.
This retrospective study could not evaluate true 
palliative radiotherapy utilization rates, but the per-
ception that palliative radiotherapy is underutilized 
may be related to limited training for most pediatric 
oncologists in palliative care and palliative radio-
therapy. Many oncologists treating adults have also 
been found to have limited palliative care training, 
and better education regarding pain and symptom 
management for end-of-life care has been suggested 9. 
Some of our survey respondents indicated that pedi-
atric oncologists are reluctant to accept their patients 
as “palliative” and delay referral for palliative radio-
therapy for that reason.
Our study also noted that utilization of palliative 
radiotherapy was particularly low for indications such 
as hemoptysis and bleeding tumours. This low referral 
rate may in part result from a lack of knowledge or 
a lower prevalence of these symptoms in the pedi-
atric oncology population. With a lack of pertinent 
literature, the prevalence of these symptoms in the 
pediatric population is largely unknown, and the role 
of radiotherapy is not entirely clear. However, there 
is no reason to believe that palliative radiotherapy 
would be any less effective in children than it is in 
adults. The adult literature 9,10 also suggests that, 
although bone and brain metastases and malignant 
spinal cord compression are well-known indications 
for palliative radiotherapy, the value of radiotherapy 
for managing other symptoms—including hemoptysis 
and bleeding, and painful soft-tissue lesions—is less 
well known among non-radiation oncologists. Our 
results among pediatric oncologists appear consistent 
with those findings.
As identified by our respondents, the most 
significant barriers to the utilization of palliative 
radiotherapy involve patient and family factors, espe-
cially reluctance on the part of patients and families 
to engage in palliative radiotherapy. Experience in 
the adult palliative care population suggests that 
patients are sometimes reluctant to consider pallia-
tive radiotherapy because they do not want to spend 
precious remaining time receiving treatments or 
they do not understand the role of palliative radio-
therapy for symptom relief regardless of the incur-
able nature of the tumour. Careful explanation of the 
fewer treatments and relatively little toxicity 1,19,20 
can sometimes alleviate reluctance and encourage 
patients to consider palliative treatment. Whether a 
similar reluctance plays a role in the pediatric cancer 
population is unclear. However, our study highlights 
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t a b l e  i  Comments of pediatric oncologists regarding palliative 
radiotherapy
“Pediatric oncologists ... are somewhat reluctant to accept the 
inevitable outcome in some cases, and referral is delayed, causing 
delay in palliative radiotherapy.”
“It’s easy to contemplate radiotherapy if you’re in a centre that 
can provide it.... If you need to travel, this can be much more 
difficult to arrange and support.”
“I feel that a broader knowledge of the potential benefits of 
radiation for these children would improve q o l .”
“It will be excellent ... to produce Canadian guidelines where 
palliative radiotherapy in children will be a valid consideration.”
t a b l e  ii  Barriers to palliative radiotherapy use based on published 
studies 4–6,18
Lack of education or deficiencies in training
Perceived patient and family reluctance
Distance from radiotherapy facility or transportation difficulties
Concerns about the efficacy of radiotherapy and delayed onset of 
symptom relief
Concerns about potential radiation toxicity
Short patient life expectancy and poor patient performance status
Perceived protracted course of treatment
Patient age (older patients are usually less likely to be referred 
among adult population)
Waiting times for assessment and treatment by radiation 
oncologists
Poor communication with oncologists
Lack of coordinated end-of-life care
Lack of treatment guidelines
Costs associated with palliative radiotherapy treatment52
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a need that has been identified before 9 for radiation 
oncologists to be more involved in end-of-life issues 
for cancer patients and to work collaboratively with 
the pediatric oncology health care team to be able 
to offer palliative radiotherapy in a timely, efficient, 
and effective manner. Radiation oncologists dealing 
with pediatric patients clearly need to become more 
involved with symptom management for children 
with incurable cancers, and both ongoing research 
into, and development of guidelines for, the use of 
palliative radiotherapy in the pediatric oncology 
population would be helpful.
Not surprisingly, clinicians with past training in 
and greater knowledge of palliative care are more 
likely to refer for palliative radiotherapy. Although 
skills and knowledge in palliative care are key parts of 
caring for oncology patients, most of our respondents 
had not received formal training in palliative care. 
Training and education in palliative care are lacking 
in most pediatric residency programs 21 despite the 
fact that such education can enhance the palliative 
care knowledge of learners in those programs 22. 
Continuing postgraduate medical education for 
practicing pediatric oncologists should also highlight 
the importance of palliative care and palliative radio-
therapy education, ensuring that this knowledge is 
considered an essential aspect of caring for children 
with cancer. The number of children dying from 
cancer is low; however, pediatric oncology training 
programs need to emphasize the effect of palliative 
care on symptom control for all children with cancer. 
Improved education in palliative care and palliative 
radiotherapy may increase referral rates in the pedi-
atric patient population and may increase the overall 
quality of care.
Concerns remain that fear of radiation side effects 
may discourage oncologists from referring for radio-
therapy. Some of the reasons cited, such as second ma-
lignancy, are not relevant in the non-curative setting, 
especially given that patients are unlikely to survive 
long enough to develop a second malignancy (a side 
effect that tends to occur only one or more decades 
later). Other radiation side effects such as nausea, 
vomiting, and mucositis are often less problematic in 
a palliative population, because the doses are smaller 
than in curative setting, and the side effects that do 
occur can usually be prevented or treated effectively 
with relatively simple approaches 1,6,23,24. It would 
be important in future studies to determine which 
side effects of radiotherapy are suffered by children 
receiving palliative doses and how well those side 
effects are managed.
Our study has several limitations. First, the 
retrospective design inherent in survey evaluations 
means that physician recall may be unreliable; actual 
patient referrals for palliative radiotherapy could 
not be independently verified. Although palliative 
radiotherapy was defined in the questionnaire, re-
spondents may have varied in their own conception 
of palliative radiotherapy, and they may have varied 
in their conception of which patients were palliative. 
Also, the questions evaluating palliative radiotherapy 
indications were not exhaustive or validated, and 
they may not have accurately reflected palliative 
radiotherapy knowledge. However, the goal here 
was simply to assess whether common indications 
for palliative radiotherapy were known, rather than 
to fully assess knowledge, and the results were en-
tirely consistent with published studies looking at 
physicians caring for adult oncology patients. Also, 
because our response rate was high, and because 
most of the pediatric oncologists in the country were 
represented, we believe that our results likely provide 
an adequate reflection of current knowledge about 
indications for referral.
5.  CONCLUSIONS
Our study highlights some of the gaps in knowledge 
about palliative radiotherapy among pediatric oncolo-
gists in Canada and about the perceived underutiliza-
tion of this treatment modality. Greater involvement 
by radiation oncologists is needed in pediatric pal-
liative care, as is development of guidelines and 
educational initiatives that improve palliative care 
teaching for trainees in pediatric oncology fellowship 
programs and that place more emphasis on palliative 
radiotherapy. Initiatives of that kind may increase 
utilization of palliative radiotherapy, and in turn, lead 
to improved symptom management for children with 
advanced and incurable cancers.
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a p p e n d i x  a
Survey Questionnaire
Palliative radiotherapy for symptom management in 
palliative paediatric oncology patients in Canada.
*  Definition of palliative radiotherapy: Radiation 
therapy which is not considered curative and in 
which the primary intent is symptom relief.
A.  Background Information:
1.  Which of the following best describes your role?
a.  Paediatric Oncologist and/or Paediatric 
Haematologist
b.  Radiation Oncologist
c.  Palliative Care Physician with training in 
adult palliative care only
d.  Palliative Care Physician with training in 
pediatric palliative care
e.  Paediatric Haem/Onc Fellow
f.  Paediatrician
g.  Anaesthetist
h.  Nurse
i.  Family Physician
2.  How many children have you seen for pallia-
tive care in the last 12 months?
a.  None
b.  1–5
c.  6–10
d.  11–20
e.  >20
3.  How many children have you referred for 
assessment for palliative radiotherapy in the 
past 12 months?
a.  None
b.  1–5
c.  6–10
d.  >10
4.  Have you received palliative care training?
a.  Yes
b.  No
If yes, please indicate the number of weeks: 
__________ weeks
Please indicate the format:
a.  certified training in a palliative medi-
cine fellowship54
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b.  rotation in a training program other 
than palliative medicine
c.  workshops/lectures
d.  other: ________________________
5.  Have you received radiation oncology expe-
rience in your training? (If you are a Radiation 
Oncologist, skip to question 8)
a.  Yes
b.  No
If yes, please indicate the number of weeks: 
__________ weeks
6.  Do you have access to a Radiation Oncologist 
with expertise in Paediatric Radiotherapy?
a.  yes
b.  no
c.  unsure
7.  Do you routinely consider radiotherapy as an 
option for the palliation or symptom control 
of your pediatric patients with cancer?
a.  Yes
b.  No
c.  Never
If no or never, please specify why not.
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
8.  Please identify any of the following indica-
tions for which you have requested palliative 
radiotherapy for children in the past, or for 
which you have treated a child.
a.  bone metastasis
b.  impending fracture
c.  painful soft tissue tumor
d.  chest pain with lung mass
e.  superior vena cave obstruction
f.  brain metastasis
g.  spinal cord compression
h.  tumor induced hemoptysis
i.  splenomegaly
j.  hepatomegaly
k.  bleeding of a tumor mass
l.  shortness of breath due to intrathoracic 
tumor
m.  other ___________________________
B.  Knowledge of Palliative Radiotherapy
9.  How effective do you consider radiotherapy 
for the treatment of the following cancer 
related symptoms? Please circle the most ap-
propriate response.
Not
effective
Somewhat
effective
Very
effective
Don’t
know
a. Painful bony metastases 1 2 3 4
b. Pathological/impending 
fracture
1 2 3 4
c. Painful soft tissue tumour 
mass
1 2 3 4
d. Chest pain with lung mass 1 2 3 4
e. Superior vena cava 
obstruction
1 2 3 4
f. Brain metastasis  1 2 3 4
g. Spinal cord compression 1 2 3 4
h. Shortness of breath due to 
intrathoracic tumour
1 2 3 4
i. Tumour induced 
hemoptysis
1 2 3 4
j. Splenomegaly 1 2 3 4
k. Bleeding from a tumour 
mass
1 2 3 4
l. Hepatomegaly 1 2 3 4
10. Please review the following potential barri-
ers to your consideration of radiotherapy in 
children with cancer. Indicate how much each 
factor influences your decision.
Not
at all
A
little
Somewhat A
lot
Lack of indication in children 1 2 3 4
Personal lack of knowledge re: 
indications and use of palliative 
radiation in children
1 2 3 4
Concern regarding severity and 
duration of side effects
1 2 3 4
Transportation difficulties 1 2 3 4
Distance child lives from cancer center 1 2 3 4
Too traumatic for patient and family 1 2 3 4
Life expectancy of the child too short 1 2 3 4
Treatment results will not impact on 
quality of life of the child
1 2 3 4
No specific Paediatric Radiation On-
cology expertise locally available
1 2 3 4
Patient or family reluctance 1 2 3 4
11. Do you feel that you have adequate knowl-
edge to identify indications for palliative 
radiotherapy treatment in children?
a.  Yes
b.  No
c.  Unsure
12. Do you consider that radiotherapy is under-
utilized as a treatment modality in palliation 
for children with cancer?
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a.  Yes
b.  No
c.  Unsure
Comments
___________________________________
___________________________________
____________________________________
13. Have you seen harmful side effects or seque-
lae of radiotherapy that have discouraged you 
from its use?
a.  Yes
b.  No
Please explain:
___________________________________
___________________________________
___________________________________
THANK YOU for your assistance! Other comments?
_________________________________________
_________________________________________
_________________________________________
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